Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma

Background: Programmed death ligand-1 (PD-L1) is a biomarker for assessing the immune microenvironment, prognosis, and response to immune checkpoint inhibitors in the clinical treatment of lung adenocarcinoma (LUAD), but it does not work for all patients. This study aims to discover alternative biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Zhi, Rong, Xueyao, Dai, Ziyu, Zhou, Dongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092026/
https://www.ncbi.nlm.nih.gov/pubmed/35571056
http://dx.doi.org/10.3389/fgene.2022.863796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092026/
https://www.ncbi.nlm.nih.gov/pubmed/35571056
http://dx.doi.org/10.3389/fgene.2022.863796

Ejemplares similares